Consumer confidence tumbled after nationwide protests and a sell-off of government bonds raised questions on the feasibility ...

EXCLUSIVE: The U.K. drugmaker currently has five approved cancer medicines and a clinical-stage portfolio of about 15 assets.

Like-for-like net revenue in North America fell 1.3%, but the company said it anticipates a rebound from Lysol and North ...

Japan’s financial authorities are stepping up cybersecurity efforts after the fallout from an attack on a server-hosting ...

The luxury sports-car maker said it continued to reap early benefits from a strategic reset.

The Cronos project off Cyprus in the eastern Mediterranean lays the foundation for future drilling in the region, according ...

President Trump escalated his attacks on Democratic Senate nominee Abdul El-Sayed, linking him to the Muslim Brotherhood and ...

The investment comes as Nvidia and Meta Platforms expand their partnership on the Facebook parent’s artificial-intelligence ...

The Swiss drugmaker cited solid sales growth and productivity gains, even as recent clinical-trial setbacks hit its bottom line in the third quarter.

The bank said quarterly results were supported by growth in banking net interest income and lower expected credit losses.

A Deloitte study found a booming market in stock-based loans to billionaires—and the lesser rich.

Software firms account for about a third of the risky corporate loans due in 2028 and 2029.